- Avicanna (AVCN) partner Viola will launch nationwide through Shoppers’ medical cannabis online platform
- Founded in 2011 by NBA veteran Al Harrington, Viola is a cannabis producer and licensed wholesaler focused on minority representation in the cannabis industry
- Viola products will be made available across adult-use channels by the end of 2021, including Ontario and New Brunswick imminently
- Avicanna is a commercial-stage biopharmaceutical company focused on cannabinoid research, development and evidence-based products
- Avicanna (AVCN) is down by 2.56 per cent and is currently trading at $0.76 per share
Avicanna (AVCN) partner Viola will launch nationwide through Shoppers’ medical cannabis online platform.
Founded in 2011 by NBA veteran Al Harrington, Viola is a producer and licensed wholesaler of premium cannabis products with its foothold in four U.S. states. The company’s focus is to increase minority representation and employment opportunities for black and other underrepresented communities in the cannabis industry.
Viola products, distributed through Medical Cannabis by Shoppers, will be made available nationwide across adult-use channels by the end of 2021, including Ontario and New Brunswick imminently.
Products include live terpene disposable vaporizers, 510 cartridges and concentrates in both THC and CDB varieties.
Al Harrington, Co-founder and CEO of Viola Brands, stated,
“We’re excited to launch in Canada with our partner Avicanna, who shares our vision to increase representation and promote equity within the cannabis industry, and look forward to having Viola’s premium products available at Medical Cannabis by Shoppers.”
Aras Azadian, CEO of Avicanna, added,
“Today, Canada’s incredible diversity is not well represented by existing brands and through this multi-layered partnership with Viola we seek to fill that gap, bring some much-needed minority representation and extend Al’s vision to Canadian consumers.
Additionally, having Viola’s premium products launched in Canada through our distribution agreement with Medical Cannabis by Shoppers Drug Mart will be a huge win for Canadians as the products will be available nationwide immediately.”
Avicanna is a commercial-stage biopharmaceutical company focused on cannabinoid research, development and evidence-based products.
Avicanna (AVCN) is down by 2.56 per cent and is currently trading at $0.76 per share as of 9:30 am ET.
